leisure time -WSS

leisure time

author：leisure time 2025-10-02 23:31:53 - browse：59796

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Deliver public health messages at the right time

WSS

First medicine developed to treat MASH expected to be approved soon

Lawmakers grill UnitedHealth CEO on Change cyberattack

NEJM study link tiny plastics in blood vessels to heart problems

Most antidepressants don't work on kids, teens, study finds

Primary care doctor shortage won't be solved by free med school tuition

PBM executives asked to testify by House panel

hotspot

leisure time

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

Change Healthcare cyberattack prompts Medicare loan program

As demand for Covid shots wanes, Moderna seeks its next success

IVF, abortion rights issues kick off Biden’s State of the Union

Medicare details structure of new drug price negotiation program

How a small hospital in rural Puerto Rico survived Hurricane Maria

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

hotspot

Amylyx ALS drug failure raises questions and concerns

Primary care doctor shortage won't be solved by free med school tuition

Welsh Carson private equity firm escapes from FTC antitrust case

Amylyx ALS drug failure raises questions and concerns

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Crowdfunding for medical bills sidesteps core problem, author says

focus

explore

hotspot

Wikipedia